JPS57136597A - Carcinostatic substance tf-250, its preparation, and carcinostatic agent containing the same - Google Patents

Carcinostatic substance tf-250, its preparation, and carcinostatic agent containing the same

Info

Publication number
JPS57136597A
JPS57136597A JP56022274A JP2227481A JPS57136597A JP S57136597 A JPS57136597 A JP S57136597A JP 56022274 A JP56022274 A JP 56022274A JP 2227481 A JP2227481 A JP 2227481A JP S57136597 A JPS57136597 A JP S57136597A
Authority
JP
Japan
Prior art keywords
carcinostatic
exhibits
carcinoma
substance
ehrlich
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP56022274A
Other languages
English (en)
Japanese (ja)
Other versions
JPH021155B2 (enrdf_load_stackoverflow
Inventor
Kenzo Tamai
Isamu Saikawa
Takashi Yasuda
Shohachi Murakami
Toyoo Maeda
Hisatsugu Tsuda
Hiroshi Sakai
Masatoshi Sugita
Yoshiko Yamamoto
Takashi Minami
Takako Hori
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyama Chemical Co Ltd
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Priority to JP56022274A priority Critical patent/JPS57136597A/ja
Priority to US06/347,871 priority patent/US4477437A/en
Priority to DE19823205074 priority patent/DE3205074A1/de
Priority to GB8204093A priority patent/GB2093347B/en
Priority to DK069282A priority patent/DK151640C/da
Priority to CA000396425A priority patent/CA1184864A/en
Priority to IT47817/82A priority patent/IT1189224B/it
Priority to DD82237480A priority patent/DD202891A5/de
Priority to CH979/82A priority patent/CH651052A5/de
Priority to FR8202601A priority patent/FR2499855B1/fr
Priority to FI820527A priority patent/FI69096C/fi
Priority to SE8201016A priority patent/SE457000B/sv
Priority to NO820509A priority patent/NO157426C/no
Priority to NL8200640A priority patent/NL8200640A/nl
Priority to NZ199771A priority patent/NZ199771A/en
Priority to KR8200714A priority patent/KR890002256B1/ko
Priority to PT74455A priority patent/PT74455B/pt
Priority to AT0064682A priority patent/AT381722B/de
Priority to ES509774A priority patent/ES509774A0/es
Priority to BE0/207355A priority patent/BE892204A/fr
Publication of JPS57136597A publication Critical patent/JPS57136597A/ja
Priority to US06/619,895 priority patent/US4591558A/en
Priority to DK251186A priority patent/DK165641C/da
Publication of JPH021155B2 publication Critical patent/JPH021155B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
JP56022274A 1981-02-19 1981-02-19 Carcinostatic substance tf-250, its preparation, and carcinostatic agent containing the same Granted JPS57136597A (en)

Priority Applications (22)

Application Number Priority Date Filing Date Title
JP56022274A JPS57136597A (en) 1981-02-19 1981-02-19 Carcinostatic substance tf-250, its preparation, and carcinostatic agent containing the same
US06/347,871 US4477437A (en) 1981-02-19 1982-02-11 Substances having carcinostatic and immunostimulating activity
DE19823205074 DE3205074A1 (de) 1981-02-19 1982-02-12 Neue carcinostatische und immunostimulierende substanzen, verfahren zur herstellung derselben und carcinostatische mittel mit einem gehalt derselben
GB8204093A GB2093347B (en) 1981-02-19 1982-02-12 Immunostimulant material tf-2 from fusobacterium sp
DK069282A DK151640C (da) 1981-02-19 1982-02-17 Fremgangsmaade til fremstilling af forbindelser med carcinostatisk og immunostimulerende virkning
CA000396425A CA1184864A (en) 1981-02-19 1982-02-17 Substances having carcinostatic and immunostimulating activity, process for preparing the same and carcinostatic agent containing the same
IT47817/82A IT1189224B (it) 1981-02-19 1982-02-17 Sostanze carcinostatiche ed immunostimolanti tf-2,procedimento per prepararle ed agente carcinostatico che le contiene
DD82237480A DD202891A5 (de) 1981-02-19 1982-02-17 Neue carcinostatische und immunostimulierende substanzen,verfahren zu ihrer herstellung und carcinostatische mittel mit einem gehalt derselben
CH979/82A CH651052A5 (de) 1981-02-19 1982-02-17 Verfahren zur herstellung einer karzinostatischen substanz und karzinostatische substanz.
FR8202601A FR2499855B1 (fr) 1981-02-19 1982-02-17 Nouvelles substances a action carcinostatique et immuno-stimulante, procede pour les preparer a partir de bacteries du genre fusobacterium, et agent carcinostatique contenant de telles substances
FI820527A FI69096C (fi) 1981-02-19 1982-02-17 Foerfarande foer framstaellning av en karcinostatisk och immunostimulerande tf-2-substans
SE8201016A SE457000B (sv) 1981-02-19 1982-02-18 Foerfarande foer framstaellning av en carcinostatisk och immunostimulerande tf-2-substans, carcinostatisk tf-2-substans samt carcinostatiskt medel.
NO820509A NO157426C (no) 1981-02-19 1982-02-18 Fremgangsmaate for fremstilling av terapeutisk aktive forbindelser ved dyrking av mikroorganismer.
NL8200640A NL8200640A (nl) 1981-02-19 1982-02-18 Nieuwe, carcinostatische stoffen, preparaten die ze bevatten, en werkwijze voor de bereiding daarvan.
NZ199771A NZ199771A (en) 1981-02-19 1982-02-18 Carcinostatic and immunostimulating substances produced by fusobacterium nucleatum
KR8200714A KR890002256B1 (ko) 1981-02-19 1982-02-18 항암 물질 tf-2 제조 방법
PT74455A PT74455B (en) 1981-02-19 1982-02-18 Process for preparing novel substances having carcinostatic and immunostimulating activity and of a carcinostatic agent containing same
ES509774A ES509774A0 (es) 1981-02-19 1982-02-19 "un procedimiento para la preparacion de una sustancia carcinostatica tf-2".
AT0064682A AT381722B (de) 1981-02-19 1982-02-19 Verfahren zur herstellung einer neuen carcinostatischen substanz
BE0/207355A BE892204A (fr) 1981-02-19 1982-02-19 Nouvelles substances a action carcinostatique et immunq-stimulante, procede pour les preparer a partir de bacteries du genre fusobacterium, et agent carcinostatique contenat de telles substances
US06/619,895 US4591558A (en) 1981-02-19 1984-08-06 Novel substances having antitumor and immunostimulating activity, process for preparing the same and antitumor agent containing the same
DK251186A DK165641C (da) 1981-02-19 1986-05-29 Fremgangsmaade til fremstilling af tf-220, tf-230 og tf-240 forbindelser og de tilsvarende proteinfrie forbindelser

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56022274A JPS57136597A (en) 1981-02-19 1981-02-19 Carcinostatic substance tf-250, its preparation, and carcinostatic agent containing the same

Publications (2)

Publication Number Publication Date
JPS57136597A true JPS57136597A (en) 1982-08-23
JPH021155B2 JPH021155B2 (enrdf_load_stackoverflow) 1990-01-10

Family

ID=12078175

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56022274A Granted JPS57136597A (en) 1981-02-19 1981-02-19 Carcinostatic substance tf-250, its preparation, and carcinostatic agent containing the same

Country Status (1)

Country Link
JP (1) JPS57136597A (enrdf_load_stackoverflow)

Also Published As

Publication number Publication date
JPH021155B2 (enrdf_load_stackoverflow) 1990-01-10

Similar Documents

Publication Publication Date Title
HUT41718A (en) Process for preparing phenyl-carbamates and pharmaceutical compositions containing such compounds as active substances
ES2032376T3 (es) Procedimiento para preparar 2-sustituidos-(amino-sustituidos)-n-arilalquil-3-(indol-3-il)propanimidas.
JPS57136596A (en) Carcinostatic substance tf-240, its preparation, and carcinostatic agent containing the same
GB1298494A (en) Phenylethanolamine derivatives
AU528098B2 (en) Analgesic tablet
GB1263000A (en) 4,4',4''-trihydroxytriphenylmethylmethane and process for preparing it
JPS52153913A (en) Preparation of dimethylaminoethylmethacrylate
JPS57136597A (en) Carcinostatic substance tf-250, its preparation, and carcinostatic agent containing the same
JPS5391189A (en) Preparation of d-n-carbamoyl-alpha-amino acids
JPS57136598A (en) Carcinostatic substance tf-300, its preparation, and carcinostatic agent containing the same
JPS5718633A (en) Novel antibiotic, y-16482 substance, and its preparation
Chattopadhyay et al. Tumor associated macrophage mediated lysis of autologous tumor cells
JPS57136595A (en) Carcinostatic substance tf-230, its preparation, and carcinostatic agent containing the same
JPS5420195A (en) Preparation of guanosine-5'-monophosphoric acid
JPS5732295A (en) Carcinostatic substance tf-1323, its preparation, and carcinostatic agent containing the same
JPS5732294A (en) Carcinostatic substance tf-133b, its preparation, and carcinostatic agent containing the same
JPS5630995A (en) Carcinostatic substance tf-100, its preparation, and carcinostatic comprizing it
JPS5732296A (en) Carcinostatic substance tf-140, its preparation, and carcinostatic agent containing the same
JPS532436A (en) Preparation of phenols
JPS57139089A (en) Carcinostatic substance tf-350, its preparation and carcinostatic agent containing the same
JPS54107511A (en) Preparation of bio-active substance
JPS5645496A (en) Carcinostatic substance, tf-130, its preparation and carcinostatic preparation containing the same
JPS5581855A (en) Adduct of pantethine with metal salt
JPS51140146A (en) Power distribution system
JPS5756468A (en) Novel preparation of alkyl-(2-quinoxalinylmethylene) carbazinate-n1,n4-dioxide